Drug Development Lifecycle Certification

The Drug Development Lifecycle Certification is a free intermediate-level, 20-minute skill test from Science of Apps. It tests the drug development lifecycle from bench to bedside — target identification and validation, hit-to-lead and lead optimisation, ADME and pharmacokinetics, nonclinical safety under ICH M3 and GLP, the IND and first-in-human studies, Phase I to III clinical trials and ICH E6 and E8 principles, endpoints and biostatistics basics, the NDA and BLA, expedited pathways such as breakthrough and accelerated approval, the EU Clinical Trials Regulation and EMA, CMC and manufacturing under GMP, pharmacovigilance and post-marketing studies, and lifecycle management — written to FDA, EMA and ICH guidance for 2026 and 2027. Score 70% or more on its 20 questions to earn a verifiable Drug Development Lifecycle certificate (SOA-DDL). Every question is based on published standards and research — including Development and approval process: drugs (US Food and Drug Administration), About ClinicalTrials.gov (US National Library of Medicine (NIH)), Current Good Manufacturing Practice (CGMP) regulations (US Food and Drug Administration) — and each answer is explained with its source.

Science of Apps offers a free Drug Development Lifecycle Certification, written for 2026 and 2027. It tests discovery and preclinical, clinical development, regulatory review and approval and manufacturing, safety and lifecycle with 20 original scenario questions in all, each naming its published source; you get an instant score and a verifiable certificate with a credential ID you can add to LinkedIn.

Read the four skill areas on this page, then take the 20-minute test online — no fee, course or sign-up. You see every answer explained when you finish. Score 70% or more and you get a Drug Development Lifecycle certificate straight away, on screen, as a PDF and by email, with a credential ID anyone can verify.

Yes. The questions are original scenarios written by Science of Apps, and each one is based on a public source you can read: Development and approval process: drugs (US Food and Drug Administration); About ClinicalTrials.gov (US National Library of Medicine (NIH)); Current Good Manufacturing Practice (CGMP) regulations (US Food and Drug Administration); ICH M3(R2) Nonclinical safety studies for clinical trials (International Council for Harmonisation); ICH E6 Good Clinical Practice (ICH); ICH E8(R1) General considerations for clinical studies (International Council for Harmonisation). The source is shown under each question and linked in the answer review. Science of Apps doesn't copy questions from other tests.

Four skill areas with five questions each, drawn from a bank of 10 per area so a retake brings new questions: Discovery and Preclinical (Target validation, Lead optimisation and ADME and safety); Clinical Development (Trial phases, GCP and design and Endpoints and statistics); Regulatory Review and Approval (Submissions, Expedited pathways and EU and global regulation); Manufacturing, Safety and Lifecycle (CMC and GMP, Pharmacovigilance and Post-approval). Every question is an original scenario written to the 2026–2027 standard, with the published source named under it.

Pharmaceutical or biotech scientist, Clinical research professional, Regulatory affairs associate, Life sciences consultant or analyst and Biotech investor or business development professional. It suits students at leading universities, career switchers and experienced professionals who want quick, verifiable proof of Drug Development Lifecycle knowledge in 2026 and 2027.

Pre-med, public-health and biotech students (Johns Hopkins, Harvard, Karolinska, Oxford, Duke) increasingly enter industry and policy roles. Passing earns a founder-signed Science of Apps certificate with a credential ID and QR code that recruiters can verify.

Often 10 to 15 years from discovery to approval, with most candidates failing along the way, especially in Phase II where efficacy is first tested in patients.

An Investigational New Drug application submitted to the FDA before testing a new drug in humans. It includes nonclinical data, manufacturing information and the clinical protocol.

Yes. The test is online, in English and free everywhere — people take it from India, the US, the UK, Europe, Africa, Latin America and Asia-Pacific. Your certificate is dated with your own local date and can be verified from anywhere at scienceofapps.com/certification/verify/.

20 questions — 5 from each of 4 skill areas — with a 20-minute limit. You need 70% (14 of 20) to pass and 90% for distinction.

We rate it Intermediate: assumes hands-on experience in the role. It has 20 scenario questions — 5 from each of 4 skill areas — and a 20-minute limit. You need 70% (14 of 20) to pass and 90% for distinction.

Nothing. There is no fee to take a test, to receive the certificate, to have it emailed or to verify it, and no sign-up.

On our server, not in your browser. The answers never reach the page until you submit, so a certificate can only be earned by passing. Each certificate gets a unique credential ID stored by Science of Apps.

You see your score for each area and every question with the correct answer and why, with the published source behind it. You can retake after 30 minutes, and the retake draws questions you haven't seen yet.

No. Every certificate is dated, so it always shows when you passed. Retake a test any time for a newer date or a higher score.

Yes. After you pass, Add to LinkedIn opens the Licenses & certifications form with the certificate name, Science of Apps as the issuer, the issue date, your credential ID and the verification link filled in. You can also download it as a PDF or PNG, and it's emailed to you as a PDF.

Every certificate has a credential ID and a QR code. Scanning it, or entering the ID at scienceofapps.com/certification/verify/, shows the holder's name, the certification, the score and the issue date from our records.

No. They are Science of Apps' own assessments of applied skill. They aren't issued by a university or standards body, and they work best alongside a portfolio that shows the skills in real work.